Please login to the form below

Not currently logged in
Email:
Password:

Chugai appoints Ruth Currie as MD of its UK business

She replaces John Halls, who has been promoted

Ruth Currie, Chugai UKChugai Pharmaceuticals has promoted Ruth Currie to managing director of its UK business.

Currie takes over from John Halls, who also receives a promotion that sees him become managing director for Chugai's commercial activities across Europe.

In her new role, Currie will oversee all UK commercial operations of Chugai, which has been a subsidiary of Roche since 2002. She will also join Chugai's European leadership team.

Currie has been with Chugai, the original developers of RoAcemtra, since 2009, holding several senior positions, including most recently as UK sales director.

11th February 2013

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics